Neumora Therapeutics (NMRA) Prepaid Assets (2022 - 2026)

Neumora Therapeutics' Prepaid Assets history runs 5 years deep, the most recent figure standing at $6.4 million for Q1 2026.

• On a quarterly basis, Prepaid Assets rose 47.95% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 47.95% increase from a year earlier, with the FY2025 full-year figure at $8.0 million, up 52.11% from the prior year.
• Prepaid Assets eased to $6.4 million in Q1 2026 per NMRA's latest filing, from $8.0 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $24.3 million in Q4 2023 and bottomed at $1.6 million in Q3 2023.
• The 5-year median for Prepaid Assets is $5.4 million (2025), against an average of $7.3 million.
• Biggest YoY gain for Prepaid Assets was 292.27% in 2024; the steepest drop was 78.33% in 2024.
• Year by year, Prepaid Assets stood at $11.9 million in 2022, then surged by 104.18% to $24.3 million in 2023, then sank by 78.33% to $5.3 million in 2024, then jumped by 52.11% to $8.0 million in 2025, then decreased by 20.54% to $6.4 million in 2026.
• Per Business Quant, the three latest NMRA Prepaid Assets figures stand at $6.4 million (Q1 2026), $8.0 million (Q4 2025), and $5.6 million (Q3 2025).